Literature DB >> 11808755

Impact of mutations conferring reduced susceptibility to lamivudine on the response to antiretroviral therapy.

C F Perno, A Cozzi-Lepri, C Balotta, F Forbici, M Violin, A Bertoli, G Facchi, P Pezzotti, G Angarano, C Arici, P Narciso, A Orani, E Raise, A Scalzini, A Poggio, G Ippolito, M Moroni, A D Monforte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11808755

Source DB:  PubMed          Journal:  Antivir Ther        ISSN： 1359-6535


× No keyword cloud information.
  3 in total

1.  Case files from Stanford University Medical Center: Drug resistance testing in previously untreated patients with HIV--knowing what to look for and choosing appropriate therapy.

Authors:  Robert W Shafer; Dong Phuong Nguyen; W Jeffrey Fessel
Journal:  MedGenMed       Date:  2006-08-07

Review 2.  HIV-1 drug resistance mutations: an updated framework for the second decade of HAART.

Authors:  Robert W Shafer; Jonathan M Schapiro
Journal:  AIDS Rev       Date:  2008 Apr-Jun       Impact factor: 2.500

Review 3.  Genetic and phylogenetic evolution of HIV-1 in a low subtype heterogeneity epidemic: the Italian example.

Authors:  Luigi Buonaguro; Maria Tagliamonte; Maria Lina Tornesello; Franco M Buonaguro
Journal:  Retrovirology       Date:  2007-05-21       Impact factor: 4.602
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.